Pharmacogenomics of colorectal cancer in the Taiwanese population
碩士 === 中原大學 === 化學研究所 === 95 === The polymorphisms in the human genomics are various in different populations. Some of these variations can lead to differential levels in gene expression and in enzyme activity and thus can affect the metabolic pathway of 5-Fluorouracil (5-FU) and related drugs. This...
Main Authors: | Chi-Fang Chen, 陳吉芳 |
---|---|
Other Authors: | Chung-Yung Chen |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/54969422648276396465 |
Similar Items
-
Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments
by: Bruera G, et al.
Published: (2020-11-01) -
Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update
by: Nurul-Syakima Ab Mutalib, et al.
Published: (2017-10-01) -
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
by: Alessia Bignucolo, et al.
Published: (2017-07-01) -
Pharmacogenomic identification of novel markers of response to chemotherapy in colorectal cancer
by: McLean, Estelle Grace
Published: (2006) -
Pharmacogenomic identification and analysis of determinants of response to chemotherapy in colorectal cancer
by: McCulla, Andrea Anna Louise
Published: (2006)